First Covid-19 vaccine clinical trial in Catalonia begins
Girona area pharmaceutical company Hipra tests its jab on 30 volunteers
Girona area pharmaceutical company Hipra tests its jab on 30 volunteers
The sector celebrates the outcome showing they can operate safely ahead of clubs reopening from June 21
400 party-goers will be allowed on "Sin Street" after testing negative for Covid-19
Camp Nou one of four venues attending to participants taking part in innovative coronavirus research project
"Each person testing positive infects 5 to 15% of their contacts; we need to stop it," says researcher of study partly funded by Bill & Melinda Gates Foundation
Health minister Alba Vergés announces that first results will be out in three weeks
Vall d’Hebron Oncology Institute helps prove efficacy of personalized treatment for BRCA gene mutation carriers
A clinical trial of a vaccine has proved, for the first time ever, that the immune system of those infected with AIDS can be re-educated in order to control the virus for long periods of time and without taking anti-retroviral drugs. In particular, 5 of the 13 patients whom participated in the trial and stopped their treatment achieved control of the virus for 5, 13, 17, 20 and 27 weeks respectively. The research, which is still ongoing, is being developed in different hospitals in Barcelona and Badalona and is directed by the IrsiCaixa AIDS Research Institute, a leading centre for research into the eradication of HIV/AIDS and related diseases, and the Fight AIDS Foundation, a non-profit organisation that is dedicated to healthcare, research and education in the field of HIV/AIDS, created by Doctor Bonaventura Clotet in 1992.